--- title: "AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors" type: "News" locale: "en" url: "https://longbridge.com/en/news/293517988.md" description: "AbbVie Inc. (ABBV) shares fell 1.09% to $253.30 on Wednesday, underperforming competitors like Johnson & Johnson and Pfizer during a broadly weak market session. The S&P 500 and Dow Jones also declined slightly. AbbVie closed 3.19% below its 52-week high of $261.64 set in July. Trading volume was notably lower than the 50-day average." datetime: "2026-07-22T20:31:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293517988.md) - [en](https://longbridge.com/en/news/293517988.md) - [zh-HK](https://longbridge.com/zh-HK/news/293517988.md) generator: "portal-rs" --- # AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. (ABBV) shed 1.09% to $253.30 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.14% to 7,498.96 and Dow Jones Industrial Average falling 0.01% to 52,218.58. AbbVie Inc. closed 3.19% below its 52-week high of $261.64, which the company achieved on July 2nd. The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 2.00% to $255.63, Pfizer Inc. (PFE) fell 0.48% to $24.82, and Amgen Inc. (AMGN) fell 0.05% to $366.05. Trading volume (4.8 M) remained 2.3 million below its 50-day average volume of 7.0 M. Data source: Dow Jones Market Data, FactSet. Data compiled July 22, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 07-22-26 1631ET ### Related Stocks - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md) - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) - [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md) - [FDS.US](https://longbridge.com/en/quote/FDS.US.md) ## Related News & Research - [Massachusetts Financial Services Co. MA Reduces Stock Position in AbbVie Inc. $ABBV](https://longbridge.com/en/news/296592574.md) - [AbbVie Inc. $ABBV Shares Sold by Capital Investment Advisory Services LLC](https://longbridge.com/en/news/296190656.md) - [Vest Financial LLC Sells 3,946 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/296462167.md) - [AbbVie Inc. $ABBV Shares Bought by Confluence Wealth Services Inc.](https://longbridge.com/en/news/296071377.md) - [AbbVie (ABBV) Lifted 2026 Guidance, Is The Upside Already Priced In?](https://longbridge.com/en/news/295877602.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**